Key points are not available for this paper at this time.
Coronavirus disease 2019 (COVID-19) is a global pandemic affecting 185 countries and >3 000 000 patients worldwide as of April 28, 2020. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2, which invades cells through the angiotensin-converting enzyme 2 receptor. Among patients with COVID-19, there is a high prevalence of cardiovascular disease, and >7% of patients experience myocardial injury from the infection (22% of critically ill patients). Although angiotensin-converting enzyme 2 serves as the portal for infection, the role of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers requires further investigation. COVID-19 poses a challenge for heart transplantation, affecting donor selection, immunosuppression, and posttransplant management. There are a number of promising therapies under active investigation to treat and prevent COVID-19.
Building similarity graph...
Analyzing shared references across papers
Loading...
Kevin J. Clerkin
J. Fried
J. Raikhelkar
Circulation
Columbia University
Building similarity graph...
Analyzing shared references across papers
Loading...
Clerkin et al. (Sat,) studied this question.
www.synapsesocial.com/papers/69d9646a04deaa6ab56845b5 — DOI: https://doi.org/10.1161/circulationaha.120.046941